Robert Ginyard, Chairman
Three years ago Robert Ginyard’s major battle was raising capital and reviving his tote bag business by re-launching his signature product the Shusokumb (pronounced Shu- Sock’em) Bag, a compartmentalized tote bag designed for the millions of women who wear flat shoes or sneakers to work and later change into heels once they arrive to the office. He never imagined that a year later he would be battling prostate cancer.
Suddenly, the goal of achieving entrepreneurial success with his Shusokumb Bag was not as important as overcoming prostate cancer. A former banker and marketing director, Robert has now taken on a new role in speaking out to promote prostate cancer awareness and overall good health. Robert also started DiBi Dibi, Dream it, Believe it, Do it, Be it. Robert currently serves as ZERO’s Chairman. Read more about Robert here.
Alicia Morgans, M.D., M.P.H., Vice Chair
Dr. Morgans is an Associate Professor at the The Feinberg School of Medicine at Northwestern University. She specializes in the treatment of genitourinary malignancies, including cancers of the prostate, bladder, testis (germ cell) and penis. She received a bachelor’s degree with honors in biology before going to medical school at the University of Pennsylvania School of Medicine. She then went on to complete a residency in internal medicine at the Hospital of the University of Pennsylvania in Philadelphia. Dr. Morgans completed a fellowship in Hematology/Oncology at Harvard’s Dana Farber Cancer Institute and Massachusetts General Hospital Cancer Center in Boston, before becoming an Assistant Professor of Medicine at Vanderbilt University Medical Center. She also has achieved a Masters in Public Health.
Dr. Morgans’ research focus is on improving care and patient outcomes in advanced prostate cancer. Her research investigates the side effects of cancer treatment (including the prevention, diagnosis of, and treatment of these effects) and treatment decision-making among men with advanced prostate cancer. She also has an interest in supporting clinical research of novel treatments for genitourinary malignancies. Dr. Morgans is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group. She also chairs ZERO’s Medical Advisory Board.
Ed Lomasney, Secretary and Treasurer
Ed Lomasney is the Executive Director for Client Service at Cullen Funds in Chicago. When his father was diagnosed with advanced prostate cancer, Ed decided to take an active role in the fight for a cure. With two young sons and a daughter on the way, Ed is dedicated to fighting for Generation ZERO and to ending prostate cancer as a ZERO Champion.
Previously, he served as a Managing Director with John Hancock’s Private Client Group and a Vice President at Nuveen Investments. Ed has eighteen years of experience in financial services and he has a bachelor’s degree in economics from the University of Iowa.
Thomas Bognanno is a prostate cancer survivor with advanced disease. He has been the President and CEO of CHC: Creating Healthier Communities since January 2006. He is a career nonprofit executive and the catalyst for bringing CHC: Creating Healthier Communities to the next level with innovative programs that focus on health disparities, community health development, employee engagement, workplace giving campaigns, and health resources. In his role he utilizes his decades of experience and expertise to define strategic direction and increase income for CHC: Creating Healthier Communities member organizations. Prior to his current position, Tom spent two decades with the American Diabetes Association, and before that with the American Cancer Society.
Jonathan D. Schwartz
Jonathan D. Schwartz is a Lean Champion at American Capital, where he works with portfolio companies to improve their performance. Prior to this position, he held several operations management, strategic planning, process improvement, project management, and customer engagement management positions at Bank of America, Vericom Corporation (health care communications company), Inner Circle Logistics (a start-up providing web-based data management tools), McKinsey & Company, Motorola, and Hewlett-Packard. Jonathan holds an MBA and MS in Mechanical Engineering from MIT and a BS in Industrial Engineering from Stanford University.
Jonathan served as Chairman of the Board from 2010-2016 and he is the son of ZERO’s first CEO, William A. Schwartz, who died of prostate cancer in 2002. You can read more about the Schwartz family here.
Cheryl is a veteran ZERO champion and advocate who is on a mission to educate men and families about prostate cancer. After her husband lost his battle to the disease almost eleven years ago, Cheryl – along with her daughters Tara and Meghan – connected with ZERO, and the rest is history.
For the past ten years, she has participated in ZERO’s Run/Walk – Capital Area as a top supporter raising more than $89,000. She serves as a ZERO Social Media Ambassador and each year speaks to her elected officials at the ZERO Prostate Cancer Advocacy Summit to help protect prostate cancer research funding. She is also an active community advocate who regularly volunteers and attends local events to raise awareness and funds for the cause.
Cheryl taught at Prince William County Public Schools and is a seasoned educator and resource for wives and caregivers in the prostate cancer community. During her tenure in the school system, she served on Advisory Councils for over 10 years as both a member and chairperson for grades K – 12. As a parent, she was a willing PTO volunteer holding many positions over the years, including President. Service to the community has always been of utmost importance to Cheryl.
You can read more about Cheryl here.
Tom Hulsey is a prostate cancer survivor, endurance athlete, and champion for ZERO. As a member of Team ZERO, Tom represented ZERO at several high-profile events including the IRONMAN World Championship in Kona in 2016 and raised significant funds to help end the disease. His journey and ability to achieve physical feats have inspired many in the prostate cancer community.
Tom is a technology and cyber security professional, as well as a thought leader in cancer survivorship. Diagnosed on his 61st birthday, he utilizes his long-time love for health and fitness to not only compete in endurance events himself, but to mentor new Team ZERO athletes. He also serves as a ZERO spokesman, Social Media Ambassador, active community advocate, and volunteers at the Baylor, Scott & White Cancer Health & Wellness Center in Plano, TX. In 2017 he was named a peer reviewer for the Prostate Cancer Research Program at the Congressionally Directed Medical Research Programs in the Department of Defense. He’s also authoring a book on his prostate cancer journey, a beacon of hope and inspiration for cancer survivors. You can read more about Tom here.
Kelvin Moses, M.D., Ph.D., FACS
Dr. Moses is a member of ZERO’s Medical Advisory Board and serves as an Assistant Professor of Urology in the Department of Urologic Surgery at Vanderbilt University Medical Center. He received both his M.D. and a Ph.D from the Baylor College of Medicine and is a foremost expert on prostate cancer in the African American community as well as the topic of cancer disparities in the United States. Dr. Moses is a frequent speaker at the ZERO Annual Advocacy Summit, discussing topics ranging from what high-risk men should know about the disease to sexual health after treatment.
Brad D. Lerner, M.D.
Brad D. Lerner, M.D., practices general urology and his specific clinical interests include vasectomy, male infertility, erectile dysfunction including prosthesis for the treatment of ED, kidney stones, sperm retrieval procedures, and benign prostatic hyperplasia (BPH or enlarged prostate). He also performs the UroLift procedure for the treatment of BPH/enlarged prostate.
Dr. Lerner became President of Chesapeake Urology Associates, LLC in August 2016. He also serves as the organization’s Medical Director of its Summit Ambulatory Surgical Centers. Previously, he was the Co-Director of Reproductive Medicine, Microsurgery and Sexuality and Director of the Peer Review and Quality Assurance/Quality Performance Committees.
Dr. Lerner maintains a clinical urology practice at Union Memorial Hospital, where he is Chief, Division of Urology. He is also the Urology Consultant for the NFL Baltimore Ravens.
Don Slaght is the Managing Principal of The Hollston Group, Hollston Hills LLC and Hollston Realty Group. Diagnosed with prostate cancer in 2016, Don almost instantly jumped into action and initiated a relationship with ZERO. In just a few years, he’s become an integral part of building ZERO’s presence in New Jersey. Don is a charter member of the New Jersey Champions for ZERO.
Don is also a two-time former Chairman of the Board of Directors of Special Olympics New Jersey and an active supporter of numerous Jersey Shore based charities, as well as the Cape Cod based Grant W. Koch Scholarship Fund.
Dan Perkins serves as the Executive Pastor at WestGate Church in San Jose, California, and has served on the Board of Directors for Silicon Valley Triathlon Club and FCA-Endurance. Perkins became involved in the prostate cancer cause in 2012 after losing one of his best friends to the disease. Since then, he has raised more than $90,000 for men and families by competing in numerous triathlons and endurance events as a member and fundraiser for Team ZERO. Perkins is also a regular attendee at the annual ZERO Summit, where he joins other advocates on Capitol Hill to meet with their elected officials to advance critical research funding for prostate cancer.
Karen Jauregui became involved in the prostate cancer cause after her beloved husband Peter passed away from the disease in 2017. She captains the team “Soaring Eagle” for the annual Boston Run/Walk and was a top fundraiser in 2019 and 2020. Based in the greater Boston area, Jauregui is the Head of Regulatory Affairs & Quality at Imbria Pharmaceuticals (which doesn’t have any pending investments in prostate cancer), where she is involved in new drug development for cardiovascular diseases and oversees regulatory affairs and quality assurance.